SLCO1B1 and hepatocellular carcinoma: Authors of another study reported germline mutations in OATP1B1, c.388A>G (p.Asn130Asp) and c.521T>C (p.Val174Ala), which are associated with emerging side effects of sorafenib in HCC patients [100].